A recent report published by TheBusinessResearchCompany on Hormonal Contraceptives Market provides in-depth analysis of segments and sub-segments in the global as well as regional. http://bit.ly/2N3IWZr
The Global Combined Hormonal Contraceptives Market witnessed a rapid growth in the historic period from 2016 to 2019 and is anticipated to witness significant growth during the forecast period.
A report from TheBusinessResearchCompany shows that the "Global Hormonal Contraceptives Market 2019" is expected to grow to $15.39 billion at a CAGR of 3.6% through 2022. Read more at https://bit.ly/2ZzJ3zr
According to the latest research report by IMARC Group, The United States premenstrual syndrome treatment market size is projected to exhibit a growth rate (CAGR) of 3.90% during 2024-2032. More Info:- https://www.imarcgroup.com/united-states-premenstrual-syndrome-treatment-market
Global Hormonal Contraceptives Market by The Business Research Company is segmented as Oral Contraceptive Pills, Injectable Birth Control, Emergency Contraceptive Pills, Vaginal Rings, Others https://bit.ly/2Wx1cC1
Get FREE Sample of this Report at https://bit.ly/3kCHi0f Global Combined hormonal contraceptive Market research report includes specific segments by region (country), by company, by Type and by Application.
The global women’s health market is expected to reach USD 24.48 Billion by 2027, according to a new report by Emergen Research. The women’s healthcare market is experiencing high demand attributable to a growing demand for devices (intrauterine devices, vaginal rings, and implants) and drugs (Prolia, Evista, Xgeva, Mirena, and Zometa, among others) in applications comprising contraceptives, postmenopausal osteoporosis, hormonal infertility, menopause, endometriosis, and polycystic ovary syndrome (PCOS), among others.
Global Gynecology Drugs Market by The Business Research Company is segmented as Hormonal Therapy, Non-Hormonal Therapy, Gynecology Cancers, Menopausal Disorder, Polycystic Ovary Syndrome, Contraception, Others
The global sleep apnea devices market is expected to grow at a CAGR of 16.6% during the forecast period of 2014 to 2019. North America is the largest market in the global sleep apnea devices market, with a market share of 51.8% as of 2013, followed by Europe and Asia. The global sleep apnea devices market is broadly classified on the basis of segments, namely sleep apnea therapeutic devices and sleep apnea diagnostic devices. See Full Report: http://bit.ly/1JaPNW6
This report provides analysis of the worlds leading players in the gut and digestive health industry, the key ingredients occupying the major shares, with a clear insight and commentary on the developments and trends. With the huge market potential and growth, gut and digestive health market is likely to witness a positive shift. See Full Report : http://bit.ly/1GRr1uQ
The report on Womens Health Market by treatment type (hormonal, non-hormonal), diseases indication (hypothyroidism, osteoporosis, uterine fibroid, cancer, post-menopausal syndrome, contraceptive, urinary tract infection), distribution channel (online, hospital, retail pharmacy) trends analysis and forecasts up to 2024 studies the market sizes, key trends and opportunities in the main geographies such as North America, Europe, Asia-Pacific, Rest of the World. According to the report the Global Womens Health Market is projected to grow at a CAGR of 5.72% in terms of value over the period of 2018-2024. The growth in the world market is primarily driven by significant contribution by North America (Leading region) region to this market.
The global endometriosis market size was worth USD 1.90 billion in 2017 and is expected to grow on account of an increasing number of patients across the globe, specifically in regions such as North America and Europe. In 2015, 1.8 billion women within the age group 15 to 49 years received treatment, globally.
Breast Cancer Therapeutics Market 2019 Industry Demand, Share, Global Trend, Industry News, Business Growth, Top Key Players Update, Business Statistics, and Research Methodology by Forecast to 2025
Global gynecology drugs market size is expected to reach $54.1 Bn by 2028 at a rate of 5.4%, segmented as by therapeutics, hormonal therapy, non-hormonal therapy
The Business Research Company offers polycystic ovarian syndrome treatment market research report 2023 with industry size, share, segments and market growth
According to the latest research report by IMARC Group, The global intrauterine devices market size reached US$ 4.3 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 5.7 Billion by 2028, exhibiting a growth rate (CAGR) of 4.75% during 2023-2028. More Info:- https://www.imarcgroup.com/intrauterine-devices-market
... Pharmaceutical companies have to compete with latest forms of contraception Contraceptive vaccines Vaginal rings Intrauterine Contraception Cervical caps ...
According to the latest research report by IMARC Group, The global premenstrual syndrome treatment market size reached US$ 1,346 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 1,683 Million by 2028, exhibiting a growth rate (CAGR) of 3.9% during 2023-2028. More Info:- https://www.imarcgroup.com/premenstrual-syndrome-treatment-market
In this market research report, the global hyperspectral imaging technologies market has been broadly classified on the basis of applications For more details : http://goo.gl/pb0hfp
Pharmaceutical contract packaging market will grow at a rate of 13.42% for the forecast period of 2021 to 2028. Increase in the demand for sustainable packaging is an essential factor driving the medical polymers market.
According to #TechSci Research report, India Hospital Market stood at USD66.77 billion in FY2021 and is expected to grow at a steady CAGR of 8.32% during the forecast period. Gain more Insight: https://bit.ly/3z6Ew9Q Website: https://www.techsciresearch.com/ Market Research News: https://techsciblog.com/
Big Market Research has announced a new Report Package "North American Intrauterine Contraceptive Devices (IUCD) Market- Size, Share, Trends, Forecast, Development, Situation, Future outlook, Potential 2019" Get Complete Report at: http://www.bigmarketresearch.com/north-american-intrauterine-contraceptive-2019-market The North America intrauterine contraceptive devices market is estimated to grow at a CAGR of 0.3% from 2014 to 2019. The growth of the intrauterine contraceptive devices market is driven by factors such as increasing rate of unplanned pregnancies, effective contraception and less side effects of IUCD, implementation of the Affordable Care Act (ACA), rising initiatives of private firms directed towards reducing expenses related to abortion, funds/grants for IUCD products, and technological advancements Enquire about this report at: http://www.bigmarketresearch.com/report-enquiry/280196
In this Market research report, the “North American revenue cycle management system market” is segmented on the basis of product, component, deployment, end-user, and geography. For more details : http://goo.gl/fyI3Ld
Rising awareness, increasing number of adolescent pregnancies, and government initiatives to promote hormonal contraceptives are the key forces fueling the demand for hormonal contraceptives around the globe. The hormonal contraceptives have emerged as a reliable and safe method for preventing unintended pregnancy.
In this report, the Global “Prepacked Chromatography Columns market” is broadly classified on the basis of product types and it includes 1-100 ml, 100-1000 ml, and 1L. For more details : http://goo.gl/Zxv2bS
The global intrauterine contraceptive devices market is a competitive market with a number of market players. Bayer HealthCare AG (A subsidiary of BAYER AG) (Germany), Teva Pharmaceuticals Industries Ltd. (Israel), Actavis Plc. (Ireland), and Medicines360 (Ireland) are some of the major players operating in this market. Browse full report @ http://goo.gl/StCEXP
Oral contraceptives are highly preferable as a first-line treatment for patients without contraindications, on grounds of their efficacy in preventing recurrence of pelvic pain and endometriosis lesions. However, they are associated with possible side effects such as mood changes, nausea, and elevated blood pressure levels. Progestins, on the other hand, require to be consumed periodically, unlike oral contraceptives, which require regular consumption.
According to MRFR analysis, Intrauterine Contraceptive Devices (IUCDs) Market is expected to register a CAGR of 10.5% during the forecast period of 2019 to 2025 and was valued at USD 1364.0 Million in 2018.
Women’s Health Products Market report segments global market by application, and geography – Global Industry Insights, Trends, Outlook, and Opportunity Analysis
The North American Intrauterine Contraceptive Devices Market is estimated to grow at a CAGR of 0.3% from 2014 to 2019. The growth of this market is driven by factors such as increasing rate of unplanned pregnancies, effective contraception, fewer side effects of IUCDs, implementation of the Affordable Care Act (ACA), rising initiatives of private firms directed at reducing abortion-related expenses
Breast Cancer Therapeutics Market 2019 Fortune Business Insights report presents an in-depth analysis of the Breast Cancer Therapeutics market size, growth, share, segments, manufacturers, and technologies, key trends, market drivers, challenges, standardization, deployment models, opportunities by 2026 Browse Complete Report Details: https://www.fortunebusinessinsights.com/industry-reports/breast-cancer-therapeutics-market-100163
Contraceptive Devices Market demand rising in the upcoming years, Contraceptive devices for female are available in different types that are expected to lead
Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Intrauterine Contraceptive Devices for these regions, from 2012 to 2022
Increasing awareness about women's health, increasing occurrence rate of the condition, the rising focus on clinical trials are some of the factors boosting the endometriosis market.
Looking for infertility PCD companies? Your search ends at Gynopolis! Find top-notch solutions for fertility challenges, brought to you by leading PCD firms. Empowering women's health is our mission, and we offer a diverse range of products. Partner with us for mutual growth and access to quality offerings in the field. Explore Gynopolis now and take a step toward a brighter future! For more information Call us at +91 9094700090 or Visit https://gynopolis.in/top-6-infertility-pcd-companies/